XSHE002919
Market cap537mUSD
Jan 10, Last price
14.80CNY
1D
-2.44%
1Q
11.53%
IPO
103.02%
Name
MINGCHEN HEALTH Co Ltd
Chart & Performance
P/E
55.96
P/S
2.40
EPS
0.26
Div Yield, %
0.00%
Shrs. gr., 5y
-0.45%
Rev. gr., 5y
24.55%
Revenues
1.64b
+73.21%
Net income
70m
+177.15%
CFO
69m
-5.38%
Dividend
May 31, 20240.18 CNY/sh
Earnings
May 20, 2025
Profile
Mingchen Health Co.,Ltd. engages in the development, production, and sale of personal health care supplies in China. It offers anti-dandruff shampoos and hair conditioners, and akin care lotions. It offers its products under the Did Flower Show, MeiWang, YiCai, High-tech Health, Green effect, and Likoujian brand names. The company was formerly known as Guangdong Ming Chen Co., Ltd. and changed its name to Mingchen Health Co., Ltd. Mingchen Health Co., Ltd was founded in 1994 and is based in Shantou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 1,637,568 73.21% | 945,405 27.05% | |||||||
Cost of revenue | 1,460,716 | 905,911 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 176,851 | 39,494 | |||||||
NOPBT Margin | 10.80% | 4.18% | |||||||
Operating Taxes | (13,731) | ||||||||
Tax Rate | |||||||||
NOPAT | 190,582 | 39,494 | |||||||
Net income | 70,365 177.15% | 25,389 -80.98% | |||||||
Dividends | (36,641) | ||||||||
Dividend yield | 0.61% | ||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 28,718 | ||||||||
Long-term debt | 52,320 | 118,190 | |||||||
Deferred revenue | (10,196) | ||||||||
Other long-term liabilities | 1,288 | 1,582 | |||||||
Net debt | (116,715) | 6,198 | |||||||
| Cash flow | |||||||||
Cash from operating activities | 69,314 | 73,252 | |||||||
CAPEX | (12,703) | ||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | 65,146 | 107,638 | |||||||
| Balance | |||||||||
Cash | 169,035 | 135,933 | |||||||
Long term investments | 1 | 4,778 | |||||||
Excess cash | 87,157 | 93,441 | |||||||
Stockholders' equity | 593,942 | 464,872 | |||||||
Invested Capital | 750,178 | 714,570 | |||||||
ROIC | 26.02% | 6.33% | |||||||
ROCE | 21.12% | 4.83% | |||||||
| EV | |||||||||
Common stock shares outstanding | 219,890 | 219,525 | |||||||
Price | 25.64 -6.53% | 27.43 26.76% | |||||||
Market cap | 5,637,975 -6.37% | 6,021,559 25.18% | |||||||
EV | 5,521,260 | 6,027,757 | |||||||
EBITDA | 352,175 | 89,804 | |||||||
EV/EBITDA | 15.68 | 67.12 | |||||||
Interest | 3,679 | 1,946 | |||||||
Interest/NOPBT | 2.08% | 4.93% | |||||||